SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000882104-19-000087
Filing Date
2019-08-07
Accepted
2019-08-07 16:22:45
Documents
21
Period of Report
2019-08-07
Items
Item 2.02: Results of Operations and Financial Condition
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K pdli-201908078xkdoc.htm 8-K 34089
2 PRESS RELEASE pdli-201908078xkex991.htm EX-99.1 260322
3 PRESENTATION pdli-201908078xkex992.htm EX-99.2 7649
4 INFORMATION SHEET pdli-201908078xkex993.htm EX-99.3 170647
5 pdllogoa25.jpg GRAPHIC 123123
6 slide1b03.jpg GRAPHIC 48976
7 slide2b03.jpg GRAPHIC 199449
8 slide3b03.jpg GRAPHIC 123739
9 slide4b03.jpg GRAPHIC 97802
10 slide5b03.jpg GRAPHIC 99590
11 slide6b03.jpg GRAPHIC 155149
12 slide7b03.jpg GRAPHIC 85523
13 slide8b01.jpg GRAPHIC 146809
14 slide9a99.jpg GRAPHIC 83190
15 slidw24.jpg GRAPHIC 118018
16 slidw25.jpg GRAPHIC 143429
17 slidw26.jpg GRAPHIC 183103
18 slidw27.jpg GRAPHIC 156096
19 slidw28.jpg GRAPHIC 116436
20 slidw29.jpg GRAPHIC 79601
21 slidw30.jpg GRAPHIC 30982
  Complete submission text file 0000882104-19-000087.txt   3217314
Mailing Address 932 SOUTHWOOD BLVD INCLINE VILLAGE NV 89451
Business Address 932 SOUTHWOOD BLVD INCLINE VILLAGE NV 89451 775-832-8500
PDL BIOPHARMA, INC. (Filer) CIK: 0000882104 (see all company filings)

IRS No.: 943023969 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-19756 | Film No.: 191005820
SIC: 2836 Biological Products, (No Diagnostic Substances)